Education
About Us
Working with TipRanks
Follow Us
Charles River Laboratories Intl (CRL)
NYSE:CRL
CRL Stock Chart & Stats
$195.28
-$0.50(-0.26%)
At close: 4:00 PM EST
$195.28
-$0.50(-0.26%)
Day’s Range― - ―
52-Week Range$91.86 - $230.02
Previous CloseN/A
Volume179.29K
Average Volume (3M)1.00M
Market Cap
$9.70B
Enterprise Value$10.05B
Total Cash (Recent Filing)$182.82M
Total Debt (Recent Filing)$2.79B
Price to Earnings (P/E)―
Beta0.75
Next Earnings
Nov 05, 2025EPS Estimate
2.34Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)3.12
Shares Outstanding49,214,176
10 Day Avg. Volume1,018,083
30 Day Avg. Volume1,000,325
Financial Highlights & Ratios
PEG Ratio-9.49
Price to Book (P/B)2.76
Price to Sales (P/S)2.36
P/FCF Ratio19.07
Enterprise Value/Market Cap1.04
Enterprise Value/Revenue2.49
Enterprise Value/Gross Profit7.68
Enterprise Value/Ebitda19.02
Forecast
1Y Price Target
$183.20Price Target Upside-6.19% Downside
Rating ConsensusModerate Buy
Number of Analyst Covering13
Bulls Say, Bears Say
Bulls Say
Financial Guidance And PerformanceCRL reaffirmed their FY25 guidance for revenue and non-GAAP EPS, indicating confidence despite the uncertain macro environment.
Manufacturing Segment SaleA sale of CRL's manufacturing segment could unlock substantial value.
Strategic ReviewThe strategic review could generate significant value for Charles River Labs.
Bears Say
DSA Segment ChallengesElevated cancelations in the DSA segment have contributed to share pressure.
Investor ConcernsInvestors are broadly concerned about 2026 revenue growth.
Leadership Transition ConcernsCharles River stock is currently down about 1% on the back of the transition announcement, which reflects some investor concern over potential distraction or disruption stemming from the leadership transition during a critical period for the company.
Charles River Labs News
CRL FAQ
What was Charles River Laboratories Intl’s price range in the past 12 months?
Charles River Laboratories Intl lowest stock price was $91.86 and its highest was $230.02 in the past 12 months.
What is Charles River Laboratories Intl’s market cap?
Charles River Laboratories Intl’s market cap is $9.70B.
When is Charles River Laboratories Intl’s upcoming earnings report date?
Charles River Laboratories Intl’s upcoming earnings report date is Nov 05, 2025 which is in 7 days.
How were Charles River Laboratories Intl’s earnings last quarter?
Charles River Laboratories Intl released its earnings results on Aug 06, 2025. The company reported $3.12 earnings per share for the quarter, beating the consensus estimate of $2.502 by $0.618.
Is Charles River Laboratories Intl overvalued?
According to Wall Street analysts Charles River Laboratories Intl’s price is currently Overvalued.
Does Charles River Laboratories Intl pay dividends?
Charles River Laboratories Intl does not currently pay dividends.
What is Charles River Laboratories Intl’s EPS estimate?
Charles River Laboratories Intl’s EPS estimate is 2.34.
How many shares outstanding does Charles River Laboratories Intl have?
Charles River Laboratories Intl has 49,214,176 shares outstanding.
What happened to Charles River Laboratories Intl’s price movement after its last earnings report?
Charles River Laboratories Intl reported an EPS of $3.12 in its last earnings report, beating expectations of $2.502. Following the earnings report the stock price went down -10.245%.
Which hedge fund is a major shareholder of Charles River Laboratories Intl?
Currently, no hedge funds are holding shares in CRL
Charles River Labs Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$183.20 (-6.19% Downside)
$183.20 (-6.19% Downside)
Blogger Sentiment
Bullish
CRL Sentiment 75%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Decreased
By 499.9K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $186.1K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▲ 3.1%
Last 30 Days ▲ 7.8%
Last 30 Days ▲ 7.8%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
7.22%
12-Months-Change
Fundamentals
Return on Equity
-1.96%
Trailing 12-Months
Asset Growth
-4.88%
Trailing 12-Months
Company Description
Charles River Laboratories Intl
Charles River Laboratories (CRL) is a leading global provider of laboratory services and products for the pharmaceutical and biotechnology industries. The company specializes in early-stage drug development, offering a comprehensive suite of services including preclinical and clinical research, toxicology testing, and laboratory animal medicine. With a focus on accelerating the drug development process, CRL supports its clients through a range of solutions that integrate scientific expertise and innovative technologies.
CRL Company Deck
CRL Earnings Call
Q2 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call highlighted a solid financial performance with increased revenue and earnings per share, driven by operational improvements and favorable FX rates. The DSA segment showed signs of stabilization, but challenges remain with decreased DSA revenue and increased cancellations. The CDMO segment faced a revenue headwind due to the end of a commercial relationship. Despite these challenges, the company's strategic review and cost reductions are on track to deliver significant savings. Overall, the sentiment reflects a cautious optimism with signs of stabilization but ongoing challenges.View all CRL earnings summariesCRL Revenue Breakdown
60.53% DSA
20.48% RMS
19.00% Manufacturing
CRL Stock 12 Month Forecast
Average Price Target
$183.20
▼(-6.19% Downside)
Technical Analysis
Ownership Overview
1.08% Insiders
33.59% Mutual Funds
0.65% Other Institutional Investors
37.75% Public Companies and
Individual Investors